Claritev Corporation (CTEV) vs SOPHiA GENETICS SA (SOPH)
- Claritev Corporation CTEV 22.12 −7.29%
- SOPHiA GENETICS SA SOPH 6.73 −7.68%
Claritev Corporation and SOPHiA GENETICS SA are both Health Information Services companies. SOPHiA GENETICS SA is the larger, with a market value of $620.6M against $404.4M — 1.5× the size. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 23.7% against 6.32%. Claritev Corporation has the higher net margin (−28.5% vs −93.9%) and the higher return on invested capital (0.47% vs −196.5%). Across the 17 metrics below, Claritev Corporation leads on 12 and SOPHiA GENETICS SA on 5.
Valuation
Profitability
| Metric | CTEV | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 72.97% | 66.63% | 62.87% |
| Operating margin | 3.27% | (85.55%) | (9.45%) |
| Net margin | (28.46%) | (93.86%) | (15.48%) |
| Free cash flow margin | (1.80%) | (47.83%) | 0.00% |
| Return on equity | 172.76% | (101.22%) | (6.91%) |
| Return on assets | (5.76%) | (43.02%) | (6.28%) |
| Return on invested capital | 0.47% | (196.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack